The Journal is included in Russian and International Library and Abstract Databases:
Russain Science Index (Russia)
Electronic Library (Russia)
DOI Registration Agency (USA)
Ulrich's Periodicals Directory (USA)
Scientific Indexing Services (USA)
InfoBase Index (India)

USE OF ETHYL-METHYL-HYDROXYPYRIDINE SUCCINATE FOR IMPROVEMENTS OF AEROBIC CAPACITY AND POWER OF ATHLETES IN ICE HOCKEY

V. V. SAVOSTYANOV (1), A. V. ALEHNOVICH (2), Е. N. BEZUGLOV (3) 1 -RUSSIAN ICE HOCKEY FEDERATION, MOSCOW, RUSSIA 2 -PIROGOVRUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY, MOSCOW, RUSSIA 3 -SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY, MOSCOW, RUSSIA

Objective: To determine the effectiveness of ethyl-methyl-hydroxypyridine succinate in complex measures of the aerobics trength preparedness (aerobic capacity) improvement among ice hockey athletes. Material and methods: To improve aerobic power preparedness (aerobic capacity) athletes in ice hockey, used ethyl-methyl-hydroxypyridine succinate. During the three training camps conducted a comprehensive functional inspection in conditions of the sports arena 18 athletes elite level. Study group 9 sportswomen women's national hockey team average age of 25,8±1,4 years, received studied the connection in the first and second training camp. Group of comparison – 9 female athletes, the average age of 21,9±1,0 year, received the connection only during the first training session. Evaluated the functional indices of blood pressure, heart rate and breathing, expected to total disadaptation probability (TDP) and the intensity performed by a special work (M). Estimated execution time of the ice test» (5×54 м).
Results: As a result of the study showed improvement in execution time of the ice test older athletes main group of 3.1% (p<0,05) compared to the initial values of the indicator and on 3% (p<0,05) compared with the control group of younger athletes to the moment of completion of observations. Significant effect on hemodynamics application ethyl-methyl-hydroxypyridine succinate did not have. It is expedient to use ethyl-methyl-hydroxypyridine succinate as actoprotectors 200 mg in the morning and in the evening before a meal, within 5–7 days. As antihypoxants - 200 mg morning and evening before food for 2–3 weeks.
Conclusions: ethyl-methyl-hydroxypyridine succinate has its adaptogenic and act-protective effect.
Keywords: 
ethyl-methyl-hydroxypyridine succinate, ice hockey, adaptogen, actoprotector, antihypoxants, ice test, adaptation to load, physical performance, aerobic power preparedness.